Table 10

Univariate transfusion factors (P > .05)

Transfusion risk factor assessed for each patientORLower 95% CIUpper 95% CIP
Blood or blood component received     
    RBCs from female donor 0.62 0.35 1.08 .09 
    RBCs from previously pregnant female donor 0.79 0.45 1.38 .40 
Cytokines: sum of amounts (concentration × volume) in all units received     
    IL-6 1.14 0.997 1.30 .06 
    IL-8 1.26 0.96 1.63 .09 
    GM-CSF 1.00 0.999 1.00 .52 
    IFN-γ 1.24 0.99 1.56 .06 
    TNF-α 1.10 0.96 1.27 .18 
    Soluble CD40 ligand (sCD40L) 1.06 0.97 1.16 .22 
    Platelet factor 4 (PF4) 1.06 0.98 1.14 .14 
Neutrophil priming activity: sum of amounts (activity × volume) in all units received     
    CD11b/CD66b up-regulation 1.00 0.95 1.04 .82 
No. of leuko-reduced RBC units received by each patient, by RBC unit storage age     
    RBC units vs other units 1.02 0.90 1.15 .77 
    No. of RBC units > 7-day-old vs other RBC units 1.02 0.76 1.37 .88 
    No. of RBC units > 14 days vs other RBC units 1.03 0.87 1.23 .72 
    No. of RBC units > 21-day-old vs other RBC units 1.13 0.95 1.34 .16 
    No. of RBC units > 28-day-old vs other RBC units 1.03 0.81 1.31 .79 
    No. of RBC units > 35-day-old vs other RBC units 0.99 0.76 1.29 .95 
    Median age of all RBCs vs other RBC units 1.01 0.99 1.03 .49 
    Mean age of all RBC units 1.01 0.99 1.03 .41 
    Maximum age among all RBC units 1.01 0.99 1.03 .26 
Apheresis platelet unit storage age     
    Platelets > 3-day-old vs other platelets 0.67 0.27 1.68 .39 
    Platelets > 4-day-old vs other 1.24 0.72 2.1 .45 
    Platelet median unit age 1.07 0.96 1.20 .20 
    Platelet mean unit age 1.07 0.96 1.2 .22 
    Platelet maximum unit age 1.07 0.96 1.2 .20 
Transfusion risk factor assessed for each patientORLower 95% CIUpper 95% CIP
Blood or blood component received     
    RBCs from female donor 0.62 0.35 1.08 .09 
    RBCs from previously pregnant female donor 0.79 0.45 1.38 .40 
Cytokines: sum of amounts (concentration × volume) in all units received     
    IL-6 1.14 0.997 1.30 .06 
    IL-8 1.26 0.96 1.63 .09 
    GM-CSF 1.00 0.999 1.00 .52 
    IFN-γ 1.24 0.99 1.56 .06 
    TNF-α 1.10 0.96 1.27 .18 
    Soluble CD40 ligand (sCD40L) 1.06 0.97 1.16 .22 
    Platelet factor 4 (PF4) 1.06 0.98 1.14 .14 
Neutrophil priming activity: sum of amounts (activity × volume) in all units received     
    CD11b/CD66b up-regulation 1.00 0.95 1.04 .82 
No. of leuko-reduced RBC units received by each patient, by RBC unit storage age     
    RBC units vs other units 1.02 0.90 1.15 .77 
    No. of RBC units > 7-day-old vs other RBC units 1.02 0.76 1.37 .88 
    No. of RBC units > 14 days vs other RBC units 1.03 0.87 1.23 .72 
    No. of RBC units > 21-day-old vs other RBC units 1.13 0.95 1.34 .16 
    No. of RBC units > 28-day-old vs other RBC units 1.03 0.81 1.31 .79 
    No. of RBC units > 35-day-old vs other RBC units 0.99 0.76 1.29 .95 
    Median age of all RBCs vs other RBC units 1.01 0.99 1.03 .49 
    Mean age of all RBC units 1.01 0.99 1.03 .41 
    Maximum age among all RBC units 1.01 0.99 1.03 .26 
Apheresis platelet unit storage age     
    Platelets > 3-day-old vs other platelets 0.67 0.27 1.68 .39 
    Platelets > 4-day-old vs other 1.24 0.72 2.1 .45 
    Platelet median unit age 1.07 0.96 1.20 .20 
    Platelet mean unit age 1.07 0.96 1.2 .22 
    Platelet maximum unit age 1.07 0.96 1.2 .20 

The transfusion univariate risk factors in this table were not statistically significant. Numbers of patients who received or did not receive this transfusion risk factor are not available because multiple imputation was used for units with missing data (“Statistical methods: risk factor analysis”).

Close Modal

or Create an Account

Close Modal
Close Modal